Expression of concern reaffirmed.
Gregory D
GD
Curfman
Stephen
S
Morrissey
Jeffrey M
JM
Drazen
D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D002318:Cardiovascular Diseases / Q000139:chemically induced* / Q000453:epidemiology; D005767:Gastrointestinal Diseases / Q000139:chemically induced* / Q000517:prevention & control; D006801:Humans; D007783:Lactones / Q000009:adverse effects* / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000139:chemically induced; D009288:Naproxen / Q000009:adverse effects* / Q000627:therapeutic use; D012107:Research Design; D013450:Sulfones / Q000009:adverse effects* / Q000627:therapeutic use; D013923:Thromboembolism / Q000139:chemically induced
D007783:Lactones; D013450:Sulfones; C116926:rofecoxib; D009288:Naproxen